The impact of transcriptional mutagenesis on cellular homeostasis
Author: Ezerskyte, Monika
Date: 2018-12-07
Location: Atrium, Nobels väg 12B, Karolinska Institutet, Solna
Time: 9:30
Department: Institutet för miljömedicin / Institute of Environmental Medicine
View/ Open:
Thesis (1.092Mb)
Abstract
DNA is exposed to chemical and physical agents that represent a continuous threat to its integrity by formation of DNA lesions. Despite the existence and efficiency of DNA repair systems in cells, some lesions may not be removed, and interfere not only with the fidelity of DNA replication but also with DNA transcription. In fact, RNA polymerase can bypass non-bulky lesions, such as 8-oxoguanine (8-oxoG) and O6-methylguanine (O6-meG) and, due to base misincorporation, lead to the production of mutated RNA through a process referred to as transcriptional mutagenesis (TM). Although the concept of TM is well known, the biological consequences are still a recent discovery. While the few existing studies of TM have begun to shed light on the process, the role these seemingly transient errors might play in disease processes, especially in tumorigenesis, is currently unknown.
The overall aim of this thesis was to explore to which extent lesion-induced TM influences protein function and how this may affect cellular homeostasis in vivo. Using plasmids containing single site-specific DNA lesions placed within probe genes with established links between specific mutations and subsequent phenotypes, we confirmed that 8-oxoG and O6-meG induced TM in mammalian cells. Further, we explored the effects of TM on splicing fidelity in vivo (Paper I) and found that TM in regulatory sequences of splicing signals resulted in activation of alternative splicing sites, thus leading to the production of disease associated splice forms and/or disrupting physiological ratios between alternatively spliced isoforms. In addition, we examined effects of TM on p53 and its tumor suppressor function in human cells (Paper II). We found that expression of mutant R248W p53 due to TM was sufficient to reduce p53’s transactivation capacity of several target genes, which are required for its tumor suppressive function. Moreover, we showed that TM of p53 reduced its tumor suppressor function by impairing both proper cell cycle control and induction of apoptosis resulting in stimulated proliferation and survival. A genome-wide gene expression analysis further revealed that TM of p53 at codon 248 deregulated both the transactivation and downregulation of numerous target genes, which are crucial for its tumor suppressor function (Paper III). These deregulated genes were involved in regulation of several cellular processes, such as cell-cycle arrest, apoptosis, and DNA damage response.
To conclude, the work presented here shed light on biological effects of TM in vivo and provides evidence for possible mechanisms by which TM might contribute to human disease development. We showed for the first time that lesion-induced TM could activate alternative splicing sites in vivo, thus reducing splicing fidelity and resulting in aberrant splicing. In addition, the work presented in this thesis, together with the results from other studies, strongly suggest that TM could be a contributing mechanism in the multistep process of tumorigenesis by inactivating a tumor suppressor or activating an oncogene thus stimulating proliferation and survival of an already initiated pre-neoplastic cell.
The overall aim of this thesis was to explore to which extent lesion-induced TM influences protein function and how this may affect cellular homeostasis in vivo. Using plasmids containing single site-specific DNA lesions placed within probe genes with established links between specific mutations and subsequent phenotypes, we confirmed that 8-oxoG and O6-meG induced TM in mammalian cells. Further, we explored the effects of TM on splicing fidelity in vivo (Paper I) and found that TM in regulatory sequences of splicing signals resulted in activation of alternative splicing sites, thus leading to the production of disease associated splice forms and/or disrupting physiological ratios between alternatively spliced isoforms. In addition, we examined effects of TM on p53 and its tumor suppressor function in human cells (Paper II). We found that expression of mutant R248W p53 due to TM was sufficient to reduce p53’s transactivation capacity of several target genes, which are required for its tumor suppressive function. Moreover, we showed that TM of p53 reduced its tumor suppressor function by impairing both proper cell cycle control and induction of apoptosis resulting in stimulated proliferation and survival. A genome-wide gene expression analysis further revealed that TM of p53 at codon 248 deregulated both the transactivation and downregulation of numerous target genes, which are crucial for its tumor suppressor function (Paper III). These deregulated genes were involved in regulation of several cellular processes, such as cell-cycle arrest, apoptosis, and DNA damage response.
To conclude, the work presented here shed light on biological effects of TM in vivo and provides evidence for possible mechanisms by which TM might contribute to human disease development. We showed for the first time that lesion-induced TM could activate alternative splicing sites in vivo, thus reducing splicing fidelity and resulting in aberrant splicing. In addition, the work presented in this thesis, together with the results from other studies, strongly suggest that TM could be a contributing mechanism in the multistep process of tumorigenesis by inactivating a tumor suppressor or activating an oncogene thus stimulating proliferation and survival of an already initiated pre-neoplastic cell.
List of papers:
I. Paredes JA, Ezerskyte M, Bottai M, Dreij K. Transcriptional mutagenesis reduces splicing fidelity in mammalian cells. Nucleic Acids Research. 45(11): 6520–6529 (2017).
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Ezerskyte M, Paredes JA, Malvezzi S, Burns JA, Margison GP, Olsson M, Scicchitano DA, and Dreij K. O6-methylguanine–induced transcriptional mutagenesis reduces p53 tumor-suppressor function. PNAS. 115(18): 4731–4736 (2018).
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Ezerskyte M, Wang J, Pelechano V, Dreij K. Transcriptional mutagenesis dramatically alters genome-wide p53 transactivation landscape. [Manuscript]
I. Paredes JA, Ezerskyte M, Bottai M, Dreij K. Transcriptional mutagenesis reduces splicing fidelity in mammalian cells. Nucleic Acids Research. 45(11): 6520–6529 (2017).
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Ezerskyte M, Paredes JA, Malvezzi S, Burns JA, Margison GP, Olsson M, Scicchitano DA, and Dreij K. O6-methylguanine–induced transcriptional mutagenesis reduces p53 tumor-suppressor function. PNAS. 115(18): 4731–4736 (2018).
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Ezerskyte M, Wang J, Pelechano V, Dreij K. Transcriptional mutagenesis dramatically alters genome-wide p53 transactivation landscape. [Manuscript]
Institution: Karolinska Institutet
Supervisor: Dreij, Kristian
Co-supervisor: Stenius, Ulla; Olsson, Magnus
Issue date: 2018-11-16
Rights:
Publication year: 2018
ISBN: 978-91-7831-241-2
Statistics
Total Visits
Views | |
---|---|
The ... | 812 |
The ...(legacy) | 241 |
Total Visits Per Month
February 2024 | March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | |
---|---|---|---|---|---|---|---|
The ... | 19 | 20 | 17 | 19 | 9 | 5 | 6 |
File Visits
Views | |
---|---|
Thesis_Monika_Ezerskyte.pdf | 1450 |
Thesis_Monika_Ezerskyte.pdf(legacy) | 126 |
null(legacy) | 4 |
Top country views
Views | |
---|---|
United States | 260 |
Denmark | 129 |
Ireland | 104 |
Sweden | 100 |
Germany | 86 |
China | 66 |
Australia | 63 |
United Kingdom | 55 |
Canada | 30 |
France | 24 |
Top cities views
Views | |
---|---|
Dublin | 102 |
Ashburn | 83 |
Copenhagen | 73 |
Sydney | 61 |
Stockholm | 27 |
Montreal | 21 |
Menlo Park | 19 |
Huddinge | 14 |
Bromma | 11 |
Mountain View | 11 |